{"status": "OK", "response": {"docs": [{"type_of_material": "Schedule", "blog": [], "news_desk": "Weekend", "lead_paragraph": "A guide to movies playing at theaters in the New York City area, as well as select festivals and film series.", "headline": {"main": "Movie Listings for June 20-26", "print_headline": "The Listings: Movies"}, "abstract": null, "print_page": "16", "word_count": "3711", "_id": "53a364797988106a6836c3fc", "snippet": "A guide to movies playing at theaters in the New York City area, as well as select festivals and film series.", "source": "", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/06/20/movies/movie-listings-for-june-20-26.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Movies", "is_major": "N", "rank": "1", "name": "subject"}], "byline": [], "document_type": "article", "pub_date": "2014-06-20T00:00:00Z", "section_name": "Movies"}, {"type_of_material": "News", "blog": [], "news_desk": "SundayBusiness", "lead_paragraph": "The feisty chief of Allergan, Botox\u2019s maker, says a takeover would imperil the company\u2019s drug-discovery mission.", "headline": {"main": "Allergan, Defending Its Fort Botox", "print_headline": "The Defense of Fort Botox"}, "abstract": "Allergan, creator of Botox, has waged a fierce battle to fend off takeover attempt from Valeant Pharmaceuticals; chief executive David E I Pyott has led charge, arguing to shareholders that a merger would undermine company's drug-development and marketing acumen.", "print_page": "1", "word_count": "1409", "_id": "539c55727988103b24442ebe", "snippet": "The feisty chief of Allergan, Botox\u2019s maker, says a takeover would imperil the company\u2019s drug-discovery mission.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/06/15/business/allergan-defending-its-fort-botox.html", "multimedia": [{"subtype": "wide", "url": "images/2014/06/15/business/15-BOTOX/15-BOTOX-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/06/15/business/15-BOTOX/15-BOTOX-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/06/15/business/15-BOTOX/15-BOTOX-articleLarge.jpg", "height": 544, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/06/15/business/15-BOTOX/15-BOTOX-articleLarge.jpg", "xlargeheight": "544"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/06/15/business/15-BOTOX/15-BOTOX-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/06/15/business/15-BOTOX/15-BOTOX-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Allergan Inc", "is_major": "Y", "rank": "1", "name": "organizations"}, {"value": "Botox (Drug)", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Valeant Pharmaceuticals International Inc", "is_major": "Y", "rank": "4", "name": "organizations"}, {"value": "Inventions and Patents", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Pyott, David E I", "is_major": "Y", "rank": "6", "name": "persons"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "7", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Natasha", "lastname": "SINGER"}], "original": "By NATASHA SINGER"}, "document_type": "article", "pub_date": "2014-06-15T00:00:00Z", "section_name": "Business Day"}], "meta": {"hits": 2, "offset": 0, "time": 42}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}